Johnson and Johnson Vaccine Efficacy (Approval Data) | drbeen
Author declares no conflict of interest.
Get free trial
with access to all our lectures
DrBeen Logo

no credit card required

My Notes

Become a member to create study notes.
Sign up for free trial
Johnson and Johnson Vaccine Efficacy (Approval Data) Duration: 2079
Microbiology / Virology

Learning Objectives

FDA has granted a emergency use authorization (EUA) to Johnson and Johnson's vaccine for SARS-COV-2. In this talk we will discuss the following aspects from the briefing document:

1. What is the type, dose, storage need, and the number of shots for this vaccine?

2. Phase III trial structure, participants, demography, etc.

3. Phase III trial results and efficacy.

4. Phase III trial results for side effects.

5. Phase III trial results for immunosuppressed, pregnant, and HIV positive patients.

6. incidence of severe reactions during the trial


Dr. Mobeen Syed

Dr. Mobeen Syed

Mobeen Syed M.D, MS Graduated from King Edward Medical University. Entrepreneur, Medical Educator, CEO and founder of Drbeen corp.

Videos in this series